Transfer to Competitors. Notwithstanding anything to the contrary contained herein, during the twenty-four (24) months period commencing on the date of issuance of the Equity Securities of the Company to the Investor and prior to the initial public offering of the Company, each Investor shall not sell, transfer or dispose of such Equity Securities to any Company Competitor without the prior consent of the Board of Directors at a duly convened board meeting or via a unanimous written consent. In case a dispute arises as to whether a Person falls under the scope of Company Competitors, the Company and such Investor shall discuss in good faith on this, and the final decision shall be supported by written evidence thereof. For the avoidance of doubt, nothing in this Section 7.1(6) shall restrict the Investor from selling, transferring or disposing of any Equity Securities of the Company to any of its Affiliates.
Transfer to Competitors. No Shareholder shall, directly or indirectly, Transfer in any transaction or series of transactions (related or not) any Shares or Voting Trust Certificates to any Competitor other than pursuant to a Sale of the Company or a Public Offering.
Transfer to Competitors. Notwithstanding anything to the contrary contained herein, during the twenty-four (24) months period commencing on the date of issuance of the Equity Securities of the Company to any Investor, such Investor shall not sell, transfer or dispose of such Equity Securities to any Company Competitor without the prior consent of the Board of Directors at a duly convened board meeting or via unanimous written consent. For the avoidance of doubt, nothing in this Section 7.1(18) shall restrict GS from selling, transferring or disposing of any Equity Securities of the Company to any GPOP II Family SPV.
Transfer to Competitors. Notwithstanding anything to the contrary contained herein, during the twenty-four (24) months period commencing on the date of issuance of the Equity Securities of the Company to any Investor and/or its Affiliates, such Investor and/or its Affiliates shall not sell, transfer or dispose of such Equity Securities to any Company Competitor without the prior consent of the Board of Directors at a duly convened board meeting or via unanimous written consent.
Transfer to Competitors. Notwithstanding anything to the contrary contained herein, during the twenty-four (24) months period commencing on August 29, 2018, each Exchange Mrfresh Shareholder shall not sell, transfer or dispose of any Equity Securities of the Company held by such Exchange Mrfresh Shareholder to any Company Competitor without the prior consent of the Board of Directors at a duly convened board meeting or via unanimous written consent of the Board of Directors.
Transfer to Competitors. Notwithstanding any provision of this Agreement, no Holder may at any time Transfer all or any part of its interest in any Equity Securities now or hereafter owned or held by it to any Person in respect of whom the Board of Directors has provided a written notice, at least seven (7) days prior to the consummation of such Transfer, to the relevant Holder setting forth reasonable grounds for concluding that such Person is (i) a Person whose core or principal business (or whose Affiliate’s core or principal business) is advertising that is conducted in direct competition with any of the Group Companies, or (ii) a Person who has (or whose Affiliate has) any arrangement, understanding or agreement with any other Person referenced in (i) above for the purposes of acquiring an interest in any of the Group Companies, the consequence of which would, in the reasonable opinion of the Board of Directors, be detrimental to the Group Companies as a whole, in each case, except pursuant to an effective Registration Statement or an exercise of its rights under Section 8.5.
Transfer to Competitors. Notwithstanding anything to the contrary contained herein, (i) during the twenty-four (24) months period commencing on the date of the respective issuance of its Series C Preferred Shares, Series D1 Preferred Shares, Series E Preferred Shares, (ii) with respect to the Series E1 Preferred Shares, during the twenty-four (24) months period commencing on August 29, 2018, and (iii) with respect to the Series F Preferred Shares, during the twenty-four (24) months period commencing on the respective issuance date of such Series F Preferred Shares and prior to the initial public offering of the Company, none of the holders of such Preferred Shares shall sell, transfer or dispose of its respective Series C Preferred Shares, Series D1 Preferred Shares, Series E Preferred Shares, Series E1 Preferred Shares, and/or Series F Preferred Shares, to any Company Competitor without the prior consent of the Board of Directors. For the avoidance of doubt, nothing in this Section 2.1(viii) shall restrict (i) GS from selling, transferring or disposing of any Equity Securities of the Company to any GPOP II Family SPV, or (ii) CICC from selling, transferring or disposing of any Equity Securities of the Company to any of its Affiliates or (iii) Xiamen Investor from selling, transferring or disposing of any Equity Securities of the Company to any of its Affiliates.
Transfer to Competitors. 9.4.1 Notwithstanding the transfer rights set forth in this Article IX, neither this Agreement nor any part of the Convertible Debenture may be transferred to any Competitor of the Company or any Person who holds more than 10% of the fully diluted equity of a Competitor without the prior written consent of the Company.
Transfer to Competitors. None of the Offerees or any Investor will, without the prior written consent of the Board of Directors of the Company, knowingly transfer, in a single transaction or a series of related transactions, shares of Capital Stock representing more than 5% of the total issued and outstanding share capital of the Company (on a fully diluted basis) to any of the Competitors (a) in a private placement or (b) in a public offering if such Investor has actual knowledge that the purchaser is a Competitor. Notwithstanding the foregoing, nothing in this Section 2.2 shall in any way restrict such Investor’s ability to Dispose of any of its shares of Capital Stock (i) under Rule 144 under the Securities Act (or any similar provisions then in force) (“Rule 144”), (ii) through a broker, dealer or other market maker making a market in shares of Capital Stock, (iii) through the facilities of the New York Stock Exchange or any other securities exchange or quotation system on which shares of Capital Stock are quoted, listed or traded, (iv) to an Affiliate of such Investor or in a distribution to such Investor’s ultimate investors or (v) in a sale of the Company.
Transfer to Competitors. Upon the transfer of any shares of the Company's Preferred Stock to a Competitor of the Company (as defined below) the Information Rights, the Registration Rights and the Preemptive Rights set forth in this Investors' Rights Agreement shall immediately terminate as to the transferred shares and be of no further force or effect. A Competitor of the Company shall be as determined by resolution of the Board of Directors in its sole and absolute discretion.
